We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Finalized EMA Guideline on Cancer Drug Development Pushes Elderly Patient Studies
Finalized EMA Guideline on Cancer Drug Development Pushes Elderly Patient Studies
January 11, 2013
The European Medicines Agency (EMA) has finalized a revised guideline on anticancer drug development, placing additional emphasis on the inclusion of elderly patients in clinical trials.